These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


215 related items for PubMed ID: 185329

  • 1. Effects of interferon on cell and virus growth in transformed human cell lines.
    Fuse TK, Morinaga N.
    J Gen Virol; 1976 Oct; 33(1):7-15. PubMed ID: 185329
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the suppression of cell and virus growth in transformed human cells of leukocyte and fibroblast interferon.
    Kuwata T, Fuse A, Suzuki N, Morinaga N.
    J Gen Virol; 1979 May; 43(2):435-9. PubMed ID: 225426
    [Abstract] [Full Text] [Related]

  • 3. Effects of ouabain on the anticellular and antiviral activities of human and mouse interferon.
    Kuwata T, Fuse A, Morinaga N.
    J Gen Virol; 1977 Mar; 34(3):537-40. PubMed ID: 192839
    [Abstract] [Full Text] [Related]

  • 4. Effects of cycloheximide and puromycin on the antiviral and anticellular activities of human interferon.
    Kuwata T, Fuse A, Morinaga N.
    J Gen Virol; 1977 Oct; 37(1):195-8. PubMed ID: 199703
    [Abstract] [Full Text] [Related]

  • 5. Effects of concanavalin A on the antiviral and cell growth inhibitory action of human interferons.
    Kuwata T, Fuse A, Takayama N, Morinaga N.
    Ann N Y Acad Sci; 1980 Oct; 350():211-27. PubMed ID: 6165277
    [Abstract] [Full Text] [Related]

  • 6. Effect of cholera toxin on the antiviral and anticellular activities of human leukocyte interferon.
    Fuse A, Kuwata T.
    Infect Immun; 1979 Oct; 26(1):235-9. PubMed ID: 227795
    [Abstract] [Full Text] [Related]

  • 7. Effect of serum on the antiviral and anticellular activities of mouse interferon.
    Kading VH, Blalock JE, Gifford GE.
    Arch Virol; 1978 Oct; 56(3):237-42. PubMed ID: 205196
    [Abstract] [Full Text] [Related]

  • 8. Resistance to interferon of a human adenocarcinoma cell line, HEC-1, and its sensitivity to natural killer cell action.
    Chen HY, Sato T, Fuse A, Kuwata T, Content J.
    J Gen Virol; 1981 Jan; 52(Pt 1):177-81. PubMed ID: 6167662
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents.
    Rubin BY, Gupta SL.
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):5928-32. PubMed ID: 6160587
    [Abstract] [Full Text] [Related]

  • 11. Bovine type II interferon: activity in heterologous cells.
    Babiuk LA, Rouse BT.
    Intervirology; 1977 Oct; 8(4):250-6. PubMed ID: 194868
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sensitivity of various human lymphoblastoid cells to the antiviral and anticellular activity of human leukocyte interferon.
    Hilfenhaus J, Damm H, Johannsen R.
    Arch Virol; 1977 Oct; 54(3):271-7. PubMed ID: 407887
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.